OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
39
Results
Show all
Save search
Copy query
Show results for
Unknown
(39)
Publication Date
Release Date
2021
(10)
2024
(9)
2025
(8)
2023
(3)
2022
(3)
2019
(2)
2020
(1)
2018
(1)
2017
(1)
2014
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Molecular Identification of Adenocephalus pacificus (Cestoda) from Three Human Cases in Lima Province, Peru.
Not available
S-EPMC7462797
|
biostudies-literature
Cite
Ecological and Health Risk Assessments of an Abandoned Gold Mine (Remance, Panama): Complex Scenarios Need a Combination of Indices.
Not available
S-EPMC8431601
|
biostudies-literature
Cite
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Not available
S-EPMC7095489
|
biostudies-literature
Cite
Molecular identification and epidemiological data of
Anisakis
spp. (Nematoda: Anisakidae) larvae from Southeastern Pacific Ocean off Peru.
Not available
S-EPMC8441025
|
biostudies-literature
Cite
Influence of calcium ion-modified implant surfaces in protein adsorption and implant integration.
Not available
S-EPMC8058122
|
biostudies-literature
Cite
Fungi under fire: diagnostic capacities and antifungal availability in Peruvian healthcare facilities.
Not available
S-EPMC12323309
|
biostudies-literature
Cite
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025.
Not available
S-EPMC12633706
|
biostudies-literature
Cite
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24.
Not available
S-EPMC12164280
|
biostudies-literature
Cite
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Not available
S-EPMC11217869
|
biostudies-literature
Cite
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Not available
S-EPMC9673084
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets